KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Cash & Current Investments (2017 - 2025)

Historic Cash & Current Investments for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to $11.4 million.

  • Co-Diagnostics' Cash & Current Investments fell 6961.42% to $11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year decrease of 6961.42%. This contributed to the annual value of $29.7 million for FY2024, which is 4919.14% down from last year.
  • According to the latest figures from Q3 2025, Co-Diagnostics' Cash & Current Investments is $11.4 million, which was down 6961.42% from $13.4 million recorded in Q2 2025.
  • In the past 5 years, Co-Diagnostics' Cash & Current Investments registered a high of $98.4 million during Q1 2022, and its lowest value of $11.4 million during Q3 2025.
  • Its 5-year average for Cash & Current Investments is $60.2 million, with a median of $63.4 million in 2023.
  • Per our database at Business Quant, Co-Diagnostics' Cash & Current Investments skyrocketed by 26251.84% in 2021 and then plummeted by 7022.52% in 2025.
  • Quarter analysis of 5 years shows Co-Diagnostics' Cash & Current Investments stood at $89.9 million in 2021, then fell by 9.57% to $81.3 million in 2022, then dropped by 27.95% to $58.5 million in 2023, then tumbled by 49.19% to $29.7 million in 2024, then tumbled by 61.53% to $11.4 million in 2025.
  • Its Cash & Current Investments was $11.4 million in Q3 2025, compared to $13.4 million in Q2 2025 and $21.5 million in Q1 2025.